Tandem Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,480
| Closed | -$221K | – | 116 |
|
|
2023
Q4 | $221K | Sell |
2,480
-460
| -16% | -$41.1K | 0.14% | 106 |
|
|
2023
Q3 | $215K | Sell |
2,940
-460
| -14% | -$33.6K | 0.15% | 104 |
|
|
2023
Q2 | $283K | Hold |
3,400
| – | – | 0.18% | 97 |
|
|
2023
Q1 | $259K | Sell |
3,400
-940
| -22% | -$71.6K | 0.18% | 93 |
|
|
2022
Q4 | $360K | Sell |
4,340
-4,465
| -51% | -$371K | 0.28% | 72 |
|
|
2022
Q3 | $694K | Buy |
8,805
+210
| +2% | +$16.6K | 0.59% | 52 |
|
|
2022
Q2 | $638K | Buy |
8,595
+270
| +3% | +$20K | 0.51% | 52 |
|
|
2022
Q1 | $679K | Buy |
8,325
+2,270
| +37% | +$185K | 0.47% | 56 |
|
|
2021
Q4 | $678K | Buy |
+6,055
| New | +$678K | 0.39% | 58 |
|